Evidence map›Paper›PMID 30383204›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2019

The Importance of Heterogeneity to the Epidemiology of Tuberculosis.

James M Trauer, Peter J Dodd, M Gabriela M Gomes, Gabriela B Gomez, Rein M G J Houben, Emma S McBryde, Yayehirad A Melsew, Nicolas A Menzies, Nimalan Arinaminpathy, Sourya Shrestha and 1 more

Abstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pre-training Epidemic Time Series Forecasters with Compartmental Prototypes.KDD : proceedings. International Conference on Knowledge Discovery & Data Mining · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Superspreading and the evolution of virulence.PLoS computational biology · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Molecular epidemiology ofJournal of clinical tuberculosis and other mycobacterial diseases · 2024
    Review

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

James M TrauerSchool of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Peter J DoddHealth Economic and Decision Science, University of Sheffield, United Kingdom.
M Gabriela M GomesLiverpool School of Tropical Medicine, United Kingdom.
Gabriela B GomezDepartment of Global Health and Development, London School of Hygiene and Tropical Medicine, United Kingdom.
Rein M G J HoubenTuberculosis Centre, London School of Hygiene and Tropical Medicine, United Kingdom.
Emma S McBrydeAustralian Institute of Tropical Health and Medicine, James Cook University, Townsville, Queensland.
Yayehirad A MelsewSchool of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Nicolas A MenziesDepartment of Global Health and Population, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
Nimalan ArinaminpathyDepartment of Infectious Disease Epidemiology, School of Public Health, Imperial College London, United Kingdom.
Sourya ShresthaDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
David W DowdyDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Funding

Medical Research Council MR/P022081/1Medical Research Council MR/R015600/1
6 · The paper itself

Abstract

Although less well-recognized than for other infectious diseases, heterogeneity is a defining feature of tuberculosis (TB) epidemiology. To advance toward TB elimination, this heterogeneity must be better understood and addressed. Drivers of heterogeneity in TB epidemiology act at the level of the infectious host, organism, susceptible host, environment, and distal determinants. These effects may be amplified by social mixing patterns, while the variable latent period between infection and disease may mask heterogeneity in transmission. Reliance on notified cases may lead to misidentification of the most affected groups, as case detection is often poorest where prevalence is highest. Assuming that average rates apply across diverse groups and ignoring the effects of cohort selection may result in misunderstanding of the epidemic and the anticipated effects of control measures. Given this substantial heterogeneity, interventions targeting high-risk groups based on location, social determinants, or comorbidities could improve efficiency, but raise ethical and equity considerations.

Indexed as

Host-Pathogen InteractionsComorbidityHumansPrevalenceRisk FactorsTuberculosiscase detectionepidemiologyheterogeneityinterventionstuberculosis

Identifiers

PMID30383204
PMCPMC6579955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.